| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/29/2010 | CA2415280C Use of halogenated xanthenes as anti-cancer and anti-bacterial agents |
| 06/29/2010 | CA2405521C Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 06/29/2010 | CA2404737C Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug |
| 06/29/2010 | CA2401942C Pharmaceutical compositions for buccal and pulmonary application |
| 06/29/2010 | CA2390082C Novel hcv non-structural polypeptide |
| 06/29/2010 | CA2370477C Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 06/29/2010 | CA2336593C Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection |
| 06/29/2010 | CA2325345C Medicaments for inducing cytotoxic t-cells |
| 06/29/2010 | CA2252372C Pathogenic escherichia coli associated protein |
| 06/29/2010 | CA2236700C Immunity against pasteurella haemolytica leukotoxin |
| 06/29/2010 | CA2168409C G cap-stabilized oligonucleotides |
| 06/29/2010 | CA2163976C Methods and compositions for inhibiting cd14 mediated cell activation |
| 06/29/2010 | CA2134030C Soluble interferon .alpha.-receptor, its preparation and use |
| 06/24/2010 | WO2010071853A1 Thiazolopyridine sirtuin modulating compounds |
| 06/24/2010 | WO2010071794A1 New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic |
| 06/24/2010 | WO2010071237A1 Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent |
| 06/24/2010 | WO2010071217A1 Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using same |
| 06/24/2010 | WO2010070523A1 Monocarbams |
| 06/24/2010 | WO2010070093A1 Crystalline form c of tigecycline dihydrochloride and methods for its preparation |
| 06/24/2010 | WO2010069882A1 Isoxazole derivatives for use as fungicides |
| 06/24/2010 | WO2010069493A1 Improved combination of active agents comprising an antibiotic and a non-steroidal anti-inflammatory drug (nsaid) |
| 06/24/2010 | WO2010069147A1 Dihydropyrimidine derivatives, compositions thereof and their use |
| 06/24/2010 | WO2010032974A3 Improved production method for adefovir dipivoxil |
| 06/24/2010 | WO2010032266A3 Novel single unit carbapenem aminoglycoside formulations |
| 06/24/2010 | WO2010030582A3 Noscapine and noscapine analogs and their use in treating infectious diseases by tubulin binding inhibition |
| 06/24/2010 | WO2010019511A3 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 06/24/2010 | WO2010010112A3 Construct and method for the internalization of cargo molecules into a cell |
| 06/24/2010 | WO2010005958A3 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 06/24/2010 | WO2007095223A3 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 06/24/2010 | US20100162418 Recombinant protein s composition |
| 06/24/2010 | US20100160454 Use of 1,2-cyclohexanedimethanol, 1,4-cyclohexanedimethanol, or 2,2,4,4-tetramethyl-1,3-cyclobutanediol as microbiocides or to prevent biofilms in water, for example use in personal care applications, in fuels, or on moldings or composites |
| 06/24/2010 | US20100160444 Method to inhibit ischemia and reperfusion injury |
| 06/24/2010 | US20100160442 Formulations for cancer treatment |
| 06/24/2010 | US20100160431 Methods and Compositions for the Treatment of Viral Infections |
| 06/24/2010 | US20100160426 Crystalline genistein sodium salt dihydrate |
| 06/24/2010 | US20100160423 Small molecule antagonists of bacterial quorum-sensing receptors |
| 06/24/2010 | US20100160420 Novel simian t-cell lymphotropic virus |
| 06/24/2010 | US20100160419 Compositions and Methods for Vaccinating Against HSV-2 |
| 06/24/2010 | US20100160414 Treating Picornavirus Infection by Targeting MicroRNA miR-141 |
| 06/24/2010 | US20100160406 Histamine h3 receptor agents, preparation and therapeutic uses |
| 06/24/2010 | US20100160379 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof |
| 06/24/2010 | US20100160368 Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy |
| 06/24/2010 | US20100160355 Anti-Viral Compounds |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160287 Compounds useful as inhibitors of janus kinases |
| 06/24/2010 | US20100160284 Carbapenem antibacterials with gram-negative activity and processes for their preparation |
| 06/24/2010 | US20100160281 Monocarbams |
| 06/24/2010 | US20100160277 Compositions for combating beta-lactamase-medicated antibiotic resistance using beta-lactamase inhibitors useful for injection |
| 06/24/2010 | US20100160273 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 06/24/2010 | US20100160265 7-(1,4-dioxenyl) doxycycline; Therapy against tetracycline-resistant organisms; bactericides; bacteriostats; escherichia; straphococcus; enterococcus; anticancer agents; antidiabetic agents |
| 06/24/2010 | US20100160264 Crystalline solid forms |
| 06/24/2010 | US20100160263 7,9-substituted tetracycline compounds |
| 06/24/2010 | US20100160254 Cellulose Sulfate for the Treatment of Rhinovirus Infection |
| 06/24/2010 | US20100160247 Synthesis of deuterated morpholine derivatives |
| 06/24/2010 | US20100160245 Quercetin-Containing Compositions |
| 06/24/2010 | US20100160223 Synergetic Effects of HGF and Antibacterial Treatment |
| 06/24/2010 | US20100160221 Effect of tula on hiv |
| 06/24/2010 | US20100160215 Antibiotic compositions for the treatment of gram negative infections |
| 06/24/2010 | US20100160211 Glycopeptide phosphonate derivatives |
| 06/24/2010 | US20100159038 Natural antibiotics containing a fermentation product of garlic by lactobacilli |
| 06/24/2010 | US20100159035 Kit for treating skin infection |
| 06/24/2010 | US20100159034 Pyrrolidinone inhibitors of pde-4 |
| 06/24/2010 | US20100158992 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| 06/24/2010 | US20100158990 Transdermal method and patch for corticosteroid administration |
| 06/24/2010 | US20100158988 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 06/24/2010 | US20100158957 Aerosolized fluoroquinolones and uses thereof |
| 06/24/2010 | US20100158954 Brucella Melitensis Mutants and Methods |
| 06/24/2010 | US20100158953 Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight |
| 06/24/2010 | US20100158949 Compositions and Methods for Vaccinating Against HSV-2 |
| 06/24/2010 | US20100158948 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a |
| 06/24/2010 | US20100158947 Permissive cells and uses thereof |
| 06/24/2010 | US20100158946 Secretory IgA and IgG Antibody Inducer |
| 06/24/2010 | US20100158945 Attenuated polio viruses |
| 06/24/2010 | US20100158942 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 06/24/2010 | US20100158941 Compositions and Methods for Treating Microbial Infections |
| 06/24/2010 | US20100158940 Manufacture of booster vaccines having reduced antigen doses |
| 06/24/2010 | US20100158939 Vaccine against pandemic strains of influenza viruses |
| 06/24/2010 | US20100158938 Tetravalent Dengue Vaccines |
| 06/24/2010 | US20100158937 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
| 06/24/2010 | US20100158935 Mutant forms of streptolysin o |
| 06/24/2010 | US20100158930 Hpv antigen fusion protein vaccine compositions and uses thereof |
| 06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
| 06/24/2010 | US20100158912 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence |
| 06/24/2010 | US20100158885 Method and material for site activated complexing of biologic molecules |
| 06/24/2010 | US20100158864 Antiviral product |
| 06/24/2010 | US20100158863 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 06/24/2010 | US20100158862 Hepatitis C Virus Inhibitors |
| 06/24/2010 | US20100158860 Heterocyclic antiviral compounds |
| 06/24/2010 | US20100158849 Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant |
| 06/24/2010 | DE102008062878A1 Substituierte Furancarboxamide und ihre Verwendung Substituted Furancarboxamides and their use |
| 06/24/2010 | DE102008062863A1 Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung Substituted (thiophenyl-carbonyl) imidazolidinones and their use |
| 06/24/2010 | CA2747715A1 Thiazolopyridine sirtuin modulating compounds |
| 06/24/2010 | CA2746764A1 New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic |
| 06/24/2010 | CA2746585A1 Crystalline form c of tigecycline dihydrochloride and methods for its preparation |
| 06/24/2010 | CA2746549A1 Isoxazole derivatives for use as fungicides |
| 06/23/2010 | EP2199795A2 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 06/23/2010 | EP2199401A1 Novel K04-0144 substances and process for production thereof |
| 06/23/2010 | EP2199382A2 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin |
| 06/23/2010 | EP2199300A2 Peptidic compounds |